The 10th International Symposium on Immunobiologicals (ISI) is celebrating its tenth edition this year. Organized by Bio-Manguinhos/Fiocruz, the event will be part of the celebrations of the Institute's 50th anniversary, which is currently the largest public producer of vaccines in Latin America. The period for submitting abstracts will be from February 23rd to March 9th. The Symposium annually brings together experts, researchers, healthcare professionals, and students to discuss cutting-edge topics related to vaccines, biopharmaceuticals, and diagnostic reagents, as well as to present advances in technological development, production, management, and the market in a sector considered strategic for public health.

“ISI 2026 will take place at a historic moment for Bio-Manguinhos and reinforces the Institute's commitment that goes beyond the production of vaccines, biopharmaceuticals and diagnostic kits: it is about contributing to the production of knowledge and scientific innovation for the development of innovative solutions for the SUS (Brazilian Public Health System) and for global health,” celebrates Bio-Manguinhos director, Rosane Cuber. 

In its tenth edition, ISI celebrates a trajectory marked by scientific excellence, the exchange of knowledge, and the building of strategic partnerships. The symposium will bring together public health professionals, researchers, and students from Brazil and various other countries, creating a dynamic environment conducive to international scientific collaboration. The goal of the meeting is to foster scientific and technological development in global health, as well as to increase the visibility of scientific contributions in the field of biotechnology.

The program will cover topics ranging from vaccines and biopharmaceuticals to diagnostic reagents, including discussions on technological development, production, processing, market dynamics, and management in these segments.

In the last edition, held in May 2025, ISI registered more than 4,800 participants from 13 countries. Over the course of three days, the event featured panels and debates with 63 speakers, as well as the presentation of 156 approved scientific papers and the awarding of nine prizes, bringing together some of the most renowned experts in immunobiologicals and public health.

"ISI is a strategic space for scientific exchange and integration." Submitting papers strengthens the dissemination of knowledge and innovation in healthcare. It is very important that universities and research institutions encourage the participation of students and young researchers, who will have the opportunity to learn about modern technologies in vaccines and biopharmaceuticals discussed by national and international experts,” highlights the coordinator of the Scientific and Technological Committee and one of the founders of the event, Akira Homma.